This is an old revision of this page, as edited by 66.147.145.210 (talk) at 21:17, 3 June 2005. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 21:17, 3 June 2005 by 66.147.145.210 (talk)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Beta blockers or beta-adrenergic blocking agents are a class of drugs used to treat a variety of cardiovascular conditions and some other diseases.
Beta blockers block the action of epinephrine and norepinephrine on the β-adrenergic receptors in the body (primarily in the heart, peripheral blood vessels, bronchi, pancreas, and liver). The hormones and neurotransmitters stimulate the sympathetic nervous system by acting on these receptors.
There are three types of beta receptors: β1-receptors located mainly in the heart, and β2-receptors located all over the body, but mainly in the lungs, muscles and arterioles. β3-receptors are less well characterised, but have a role in fat metabolism.
Activation of β1-receptors by epinephrine increases the heart rate and the blood pressure, and the heart consumes more oxygen. Drugs that block these receptors therefore have the reverse effect: they lower the heart rate and blood pressure and hence are used in conditions when the heart itself is deprived of oxygen. They are routinely prescribed in patients with ischemic heart disease. In addition, beta blockers prevent the release of renin, which is a hormone produced by the kidneys which leads to constriction of blood vessels.